Omada Health CFO exercises options, sells 2,900 shares
Omada Health, Inc.’s Chief Financial Officer Steven L. Cook reported a corrected set of insider transactions combining stock option exercises with same-day share sales.
Rhea-AI Filing Summary
Omada Health, Inc.’s Chief Financial Officer Steven L. Cook reported a corrected set of insider transactions combining stock option exercises with same-day share sales. On June 24–25, 2026, he exercised options for a total of 2,900 shares of common stock at $8.01 per share and sold the same number of shares in open-market trades at weighted average prices of about $19.02 per share under a Rule 10b5-1 trading plan. Following these transactions, he directly held 187,209 shares of Omada Health common stock. This Form 4/A fully restates an earlier filing by adding the previously omitted option exercises and updating the post-transaction share balance that had been understated.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 300 | $0.00 | $0.00 |
| Exercise | Common Stock | 300 | $8.01 | $2K |
| Sale | Common Stock | 300 | $19.0033 | $6K |
| Exercise | Stock Option (Right to Buy) | 2,600 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,600 | $8.01 | $21K |
| Sale | Common Stock | 2,600 | $19.0173 | $49K |
Footnotes (5)
- F1. This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- F2. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- F3. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
exercise-and-sale transactions financial
Stock Option (Right to Buy) financial
weighted average price financial
beneficially owned regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.